SEC 13F Intelligence

Managers / Q2 2019 · view latest →

HIGHLINE CAPITAL MANAGEMENT, L.P.

CIK 0001166850 · 10 EAST 53RD STREET, 11TH FLOOR, NEW YORK, NY, 10022 · 2123322250

Reported Value
$1.4B
Q2 2019
Positions
32
Filings on Record
16
2019–present window
Filed
Aug 14, 2019
original filing

Summary

Highline Capital Management, L.P. reported $1.4B in U.S.-listed holdings across 32 positions for Q2 2019.

Its largest position, Catalent, represents 8.2% of the portfolio.

Compared with Q1 2019, the fund opened 15 new positions and exited 18.

Portfolio Metrics

Turnover
+38.2%
vs prior filed quarter
Top-10 Concentration
+53.9%
share of reported value
Largest Position
+8.2%
Catalent
New / Exited
15 / 18
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $1.6BQ1 ’19Q2 ’19: $1.4BQ3 ’19: $685MQ3 ’19Q4 ’19: $631MQ1 ’20: $411MQ1 ’20Q2 ’20: $123MQ3 ’20: $100MQ3 ’20Q4 ’20: $204MQ1 ’21: $147MQ1 ’21Q2 ’21: $120MQ3 ’21: $118MQ3 ’21Q4 ’21: $114MQ1 ’22: $82MQ1 ’22Q2 ’22: $58MQ3 ’22: $54MQ3 ’22Q4 ’22: $0filingsflow.com

Portfolio Composition

By security type
Common Stock: 81.8%Other: 10.4%NY Reg Shrs: 4.1%REIT: 3.4%ADR: 0.3%
  • Common Stock · 81.8% · $1.1B
  • Other · 10.4% · $143M
  • NY Reg Shrs · 4.1% · $56M
  • REIT · 3.4% · $46M
  • ADR · 0.3% · $4M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
CATALENT INCNEW+2.06M2.06M+$111M$111M
SANDERSON FARMS INCNEW+583.9K583.9K+$80M$80M
MTARCELORMITTAL SA LUXEMBOURGNEW+3.11M3.11M+$56M$56M
TSNTYSON FOODS INCNEW+646.1K646.1K+$52M$52M
BMRNBIOMARIN PHARMACEUTICAL INCNEW+607.0K607.0K+$52M$52M
AAPLAPPLE INCNEW+246.3K246.3K+$49M$49M
SYYSYSCO CORPNEW+618.5K618.5K+$44M$44M
ALGNALIGN TECHNOLOGY INCNEW+100.5K100.5K+$28M$28M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2019

29 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CATALENT INCCOM8.16%$111M2.06M
2IQVIQVIA HLDGS INChistory →COM6.60%$90M560.8K
3CMCCOMMERCIAL METALS COhistory →COM5.79%$79M4.43M
4GRACE W R & CO DEL NEWCOM5.43%$74M974.1K
5ELDORADO RESORTS INCCOM5.20%$71M1.54M
6ELVANTHEM INChistory →COM5.08%$69M246.0K
7ROYAL CARIBBEAN CRUISES LTDCOM4.94%$68M557.3K
8TTWOTAKE-TWO INTERACTIVE SOFTWARhistory →COM4.71%$64M567.1K
9MTARCELORMITTAL SA LUXEMBOURGhistory →NY REGISTRY SH4.11%$56M3.11M
10SANDERSON FARMS INCCOM3.84%$52M383.9K
11TSNTYSON FOODS INChistory →CL A3.82%$52M646.1K
12BMRNBIOMARIN PHARMACEUTICAL INChistory →COM3.80%$52M607.0K
13MARVELL TECHNOLOGY GROUP LTDORD3.64%$50M2.08M
14BYDBOYD GAMING CORPhistory →COM3.51%$48M1.78M
15VICIVICI PPTYS INChistory →COM3.38%$46M2.10M
16SYYSYSCO CORPhistory →COM3.20%$44M618.5K
17MTORMERITOR INChistory →COM2.90%$40M1.63M
18URGNUROGEN PHARMA LTDhistory →COM2.67%$36M1.01M
19PEGAPEGASYSTEMS INChistory →COM2.62%$36M503.3K
20ALGNALIGN TECHNOLOGY INChistory →COM2.01%$28M100.5K
21RAREULTRAGENYX PHARMACEUTICAL INhistory →COM1.81%$25M390.5K
22GLUUGLU MOBILE INChistory →COM1.63%$22M3.10M
23FAR PT ACQUISITION CORPUNIT 06/01/20251.62%$22M2.08M
24AMICUS THERAPEUTICS INCCOM1.38%$19M1.51M
25ALECALECTOR INChistory →COM0.90%$12M645.8K
26VYGRVOYAGER THERAPEUTICS INCCOM0.59%$8M296.8K
27ADPTADAPTIVE BIOTECHNOLOGIES CORCOM0.43%$6M121.0K
28HEALTH SCIENCES ACQUSTN CORPUNIT 04/01/20240.23%$3M300.0K
29ARCTARCTURUS THERAPEUTICS HLDG ICOM0.15%$2M217.9K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2022$01Jan 26, 202313F-HRchanges · EDGAR ↗
Q3 2022$54M15Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$58M13Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$82M12May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$114M15Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$118M14Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$120M15Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$147M16May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$204M25Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$100M18Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$123M19Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$411M25May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$631M22Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$685M25Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.4B32Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.6B35May 15, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.